ABBVIE Inc. (ABBV) on GreekSoup https://greeksoup.ai/stocks/us/abbv/ Every dated entry in the public record on ABBVIE Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 23 Sep 2026 00:00:00 +0000 ABBVIE Inc.: Pete Sessions (TX17) disclosed a sale, $15,001 - $50,000, traded 14 September 2026https://greeksoup.ai/stocks/us/abbv/congress/us:ABBV:congress:2026-09-18:e46367e9bdFri, 18 Sep 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> ABBVIE Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/abbv/filings/us:ABBV:filing:2026-09-03:d0f423af2dThu, 03 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ABBVIE Inc.: short interest 19,514,024 shares at the 31 August 2026 settlement, 4.40 days to coverhttps://greeksoup.ai/stocks/us/abbv/short-interest/us:ABBV:short-interest:2026-08-31:2ad98a0e69Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ABBVIE Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/abbv/filings/us:ABBV:filing:2026-08-18:feb30dc102Tue, 18 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ABBVIE Inc.: Donoghoe Nicholas (EVP, CHIEF BUS/STRAT OFFICER) sold 32,710 shares at $250.00 on 14 August 2026, $8.2 millionhttps://greeksoup.ai/stocks/us/abbv/insiders/us:ABBV:insider:2026-08-18:8b6e21935aTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> ABBVIE Inc.: Form 144, NICHOLAS DONOGHOE plans to sell 32,710 shares worth $8.2 million around 14 August 2026https://greeksoup.ai/stocks/us/abbv/planned-sales/us:ABBV:planned-sale:2026-08-14:2217f26334Fri, 14 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> ABBVIE Inc.: short interest 18,299,894 shares at the 14 August 2026 settlement, 3.57 days to coverhttps://greeksoup.ai/stocks/us/abbv/short-interest/us:ABBV:short-interest:2026-08-14:66d134a0b3Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ABBVIE Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/abbv/filings/us:ABBV:filing:2026-08-05:27f61e047cWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ABBVIE Inc. Q2 FY2026 results: revenue $17.0 billion, net income $3.6 billionhttps://greeksoup.ai/stocks/us/abbv/results/fy2026-q2/us:ABBV:result:2026-08-03:ffa920edaeMon, 03 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> ABBVIE Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/abbv/filings/us:ABBV:filing:2026-08-03:91201ca6d0Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ABBVIE Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/abbv/filings/us:ABBV:filing:2026-07-31:a5367aeee9Fri, 31 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ABBVIE Inc.: short interest 22,547,839 shares at the 31 July 2026 settlement, 3.98 days to coverhttps://greeksoup.ai/stocks/us/abbv/short-interest/us:ABBV:short-interest:2026-07-31:94e98a459dFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ABBVIE Inc.: short interest 22,632,412 shares at the 15 July 2026 settlement, 3.45 days to coverhttps://greeksoup.ai/stocks/us/abbv/short-interest/us:ABBV:short-interest:2026-07-15:d5a77bfbdeWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> ABBVIE Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/abbv/filings/us:ABBV:filing:2026-07-06:c056757dbeMon, 06 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> ABBVIE Inc.: short interest 21,899,078 shares at the 30 June 2026 settlement, 1.75 days to coverhttps://greeksoup.ai/stocks/us/abbv/short-interest/us:ABBV:short-interest:2026-06-30:ed850950c5Tue, 30 Jun 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>